These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23938063)
21. Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-alpha and melphalan: histologically characterized improved margins correlate with absence of recurrences. Grabellus F; Kraft C; Sheu SY; Ebeling P; Bauer S; Lendemans S; Schmid KW; Taeger G Ann Surg Oncol; 2009 Mar; 16(3):676-86. PubMed ID: 19130134 [TBL] [Abstract][Full Text] [Related]
22. Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Olieman AF; van Ginkel RJ; Hoekstra HJ; Mooyaart EL; Molenaar WM; Koops HS Ann Surg Oncol; 1997 Jan; 4(1):64-9. PubMed ID: 8985519 [TBL] [Abstract][Full Text] [Related]
23. A feasibility study of circulating melanoma cells in the perioperative context of hyperthermic isolated limb perfusion (HILP) in 20 patients. Michelakis D; Lasithiotakis K; Messaritakis I; Ioannou C; Perisynakis K; Souglakos I; Stamatiou D; Chlouverakis G; de Bree E; Romanos I; Zoras O Int J Hyperthermia; 2021; 38(1):70-78. PubMed ID: 33487077 [TBL] [Abstract][Full Text] [Related]
24. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalan. Grabellus F; Kraft C; Sheu-Grabellus SY; Bauer S; Podleska LE; Lauenstein TC; Pöttgen C; Konik MJ; Schmid KW; Taeger G J Surg Oncol; 2011 Apr; 103(5):371-9. PubMed ID: 21400518 [TBL] [Abstract][Full Text] [Related]
25. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept]. Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786 [TBL] [Abstract][Full Text] [Related]
29. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients. Deroose JP; van Geel AN; Burger JW; Eggermont AM; Verhoef C J Surg Oncol; 2012 May; 105(6):563-9. PubMed ID: 22020863 [TBL] [Abstract][Full Text] [Related]
30. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. Jakob J; Tunn PU; Hayes AJ; Pilz LR; Nowak K; Hohenberger P J Surg Oncol; 2014 Jun; 109(8):786-90. PubMed ID: 24619722 [TBL] [Abstract][Full Text] [Related]
31. Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes. Rastrelli M; Mocellin S; Stramare R; Brunello A; Maruzzo M; Basso U; Scarzello G; Buzzaccarini MS; Pilati P; Saadeh LM; Del Fiore SP; Tosi A; Montesco C; Campana LG; Tropea S; Rossi CR Eur J Surg Oncol; 2017 Feb; 43(2):401-406. PubMed ID: 27890347 [TBL] [Abstract][Full Text] [Related]
32. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638 [TBL] [Abstract][Full Text] [Related]
33. Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma. Jakob J; von Rege I; Weiss C; Hohenberger P Int J Hyperthermia; 2012; 28(7):591-6. PubMed ID: 22946472 [TBL] [Abstract][Full Text] [Related]
34. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147 [TBL] [Abstract][Full Text] [Related]